HSV-1-Derived Recombinant and Amplicon Vectors for Gene Transfer and Gene Therapy
Journal:
Current Gene Therapy
Volume:
5
Page:
445-457
Author(s):
Alberto L. Epstein, Peggy Marconi, Rafaela Argnani and Roberto Manservigi
Immune Response to Herpes Simplex Virus and γ134.5 Deleted HSV Vectors
Journal:
Current Gene Therapy
Volume:
5
Page:
523-530
Author(s):
Eeva K. Broberg and Veijo Hukkanen
Melanoma Immunotherapy: Past, Present, and Future
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
3461-3473
Author(s):
F. Saleh, W. Renno, I. Klepacek, G. Ibrahim, S. Asfar, H. Dashti, P. Romero, A. Dashti and A. Behbehani
Direct Evidence on the Immune-Mediated Spontaneous Regression of Human Cancer: An Incentive for Pharmaceutical Companies to Develop a Novel Anti-Cancer Vaccine
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
3531-3543
Author(s):
F. Saleh, I. Klepacek, G. Ibrahim, H. Dashti, S. Asfar, A. Behbehani, H. Al-Sayer and A. Dashti
Xanthone Derivatives: New Insights in Biological Activities
Journal:
Current Medicinal Chemistry
Volume:
12
Page:
2517-2538
Author(s):
M. M.M. Pinto, M. E. Sousa and M. S.J. Nascimento
Ligand-Targeted Liposomes for Cancer Treatment
Journal:
Current Drug Delivery
Volume:
2
Page:
369-381
Author(s):
Puja Sapra, Pradeep Tyagi and Theresa M. Allen
Carbohydrate Mimotopes in the Rational Design of Cancer Vaccines
Journal:
Current Topics in Medicinal Chemistry
Volume:
5
Page:
1171-1185
Author(s):
Anastas Pashov, Marty Perry, Michael Dyar, Marie Chow and Thomas Kieber-Emmons
Development of Anti-HIV Agents Targeting Dynamic Supramolecular Mechanism: Entry and Fusion Inhibitors Based on CXCR4/CCR5 Antagonists and gp41-C34-Remodeling Peptides
Journal:
Current HIV Research
Volume:
3
Page:
289-301
Author(s):
Hirokazu Tamamura, Akira Otaka and Nobutaka Fujii
Cholesterol and Apoe: A Target for Alzheimers Disease Therapeutics
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
4
Page:
553-567
Author(s):
Daniela Fenili and JoAnne McLaurin
Small Transthyretin (TTR) Ligands as Possible Therapeutic Agents in TTR Amyloidoses
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
4
Page:
587-596
Author(s):
M. R. Almeida, L. Gales, A. M. Damas, I. Cardoso and M. J. Saraiva